Literature DB >> 24726125

A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with multiple sclerosis.

Anna Löf Granström1, Ellen Markljung2, Katharina Fink3, Edvard Nordenskjöld2, Daniel Nilsson4, Tomas Wester5, Agneta Nordenskjöld1.   

Abstract

PURPOSE: We identified a girl with Hirschsprung's disease (HSCR) whose mother and grandmother had HSCR associated with multiple sclerosis (MS). The aim of this study was to outline mutations in HSCR-related genes and MS susceptibility alleles in these three individuals.
METHODS: The phenotypes were reviewed based on medical records. The three subjects had rectosigmoid HSCR verified with histopathology. The mother and grandmother fulfilled the McDonald criteria for MS. DNA was isolated from EDTA-preserved blood according to standard procedures. Exome sequencing aiming mainly at analyzing HSCR associated genes as well as Sanger sequencing for confirmation was performed.
RESULTS: All affected individuals carry a novel heterozygous nonsense mutation in the EDNRB gene (c.C397T,p.R133X,refNM_000115), changing an arginine at position 133 into a premature stop codon. None of the subjects were homozygous for the HLA risk alleles for MS.
CONCLUSION: We report a novel non-sense EDNRB gene mutation in a girl with HSCR and her mother and grandmother with HSCR and MS. We propose that this EDNRB gene mutation plays a role in the etiology of HSCR and also makes the subjects susceptible to MS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EDNRB gene; Hirschsprung’s disease; Multiple sclerosis

Mesh:

Substances:

Year:  2013        PMID: 24726125     DOI: 10.1016/j.jpedsurg.2013.10.027

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.

Authors:  Tomas Wester; Anna Löf Granström
Journal:  Pediatr Surg Int       Date:  2015-01-24       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.